Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Biol Blood Marrow Transplant ; 20(6): 885-90, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24583412

RESUMEN

Cytomegalovirus (CMV) replication after allogeneic hematopoietic stem cell transplantation (HSCT) was historically associated with increased nonrelapse mortality (NRM). More recently, different groups have reported an association between CMV replication and reduced risk of acute myeloid leukemia (AML) relapse. Given the conflicting results, we evaluated the impact of CMV replication and other covariates on the outcome of a retrospective cohort of 265 adults with B cell lymphoma receiving allogeneic HSCT from HLA-identical siblings or alternative donors. In time-dependent multivariate analysis, CMV replication, evaluated by pp65 antigenemia, had no independent effect on the risk of relapse (hazard ratio [HR], 1.0; 95% confidence interval [CI], .6 to 1.6; P = .9), although it was associated with a reduced overall survival (HR, 2.0; 95% CI, 1.3 to 3.2; P = .001) and an increased NRM (HR, 2.5; 95% CI, 1.1 to 5.3; P = .01). Consistently, donor and/or recipient CMV seropositivity were not associated with a different outcome relative to CMV double-negative serostatus. In multivariate models, a diagnosis of follicular lymphoma (P < .0001) and pretransplantation complete remission status (P < .0001) were the main independent predictors for improved relapse-free survival. In summary, contrary to what is observed in patients with AML, this report identifies no independent role for CMV replication or serostatus on the relapse of patients with B cell lymphomas undergoing allogeneic HSCT.


Asunto(s)
Infecciones por Citomegalovirus/virología , Citomegalovirus/fisiología , Trasplante de Células Madre Hematopoyéticas/métodos , Linfoma de Células B/terapia , Linfoma de Células B/virología , Acondicionamiento Pretrasplante/métodos , Replicación Viral/fisiología , Adolescente , Adulto , Anciano , Estudios de Cohortes , Infecciones por Citomegalovirus/sangre , Infecciones por Citomegalovirus/etiología , Femenino , Humanos , Linfoma de Células B/sangre , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Trasplante Homólogo , Resultado del Tratamiento , Adulto Joven
2.
Tumori ; 102(Suppl. 2)2016 Nov 11.
Artículo en Inglés | MEDLINE | ID: mdl-26481864

RESUMEN

AIMS AND BACKGROUND: We describe the case of a woman cured of osteosarcoma who took part in a mono-institutional study using different questionnaires to assess pediatric cancer survivors' quality of life and behavioral features 12 years after completing her cancer treatment. RESULTS: The high levels of psychological distress and psychopathologic symptoms revealed by this patient prompted us to offer her specific and prolonged support at our institution, since she refused to seek the help of other psychiatric services. The woman revealed a dysfunctional social and family setting and a borderline personality disorder. She was hospitalized after attempting suicide. No psychological distress had previously come to light during her long follow-up for cancer. CONCLUSIONS: Cancer survivors are at risk of psychological and behavioral problems, so they should be followed up over time. Questionnaires and standard scales are important, but not enough: the physician-patient relationship is crucial to bring out a patient's psychological issues and needs. This means that dedicated resources should be made available, whenever possible.


Asunto(s)
Trastornos Mentales/etiología , Trastornos Mentales/psicología , Osteosarcoma/complicaciones , Sobrevivientes/psicología , Adulto , Femenino , Humanos , Trastornos Mentales/diagnóstico , Trastornos Mentales/terapia , Calidad de Vida , Encuestas y Cuestionarios
3.
Tumori ; 101(6): 626-30, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26045110

RESUMEN

AIMS AND BACKGROUND: Adolescent patients with cancer need psychological support in order to face the traumatic event of cancer diagnosis and to preserve continuity with their normal lives. Creative projects or laboratories may help young patients express their thoughts and feelings. METHODS: The Youth Project developed activities dedicated to adolescents to give them a chance to vent their creative spirit and express themselves freely. In the first project, the teenagers designed their own fashion collection in all its various stages under the artistic direction of a well-known fashion designer, creating their own brand name (B.Live), and organized a fashion show. RESULTS: In all, 24 patients from 15 to 20 years old took part in the project. The fashion project proved a fundamental resource in helping the young patients involved to regain a positive self-image and the feeling that they could take action, both on themselves and in their relations with others. CONCLUSIONS: Facilitating the experience of beauty may enable hope to withstand the anguish caused by disease. This experience integrated the usual forms of psychological support to offer patients a form of expression and support during the course of their treatment.


Asunto(s)
Belleza , Vestuario , Creatividad , Ajuste Emocional , Esperanza , Individualidad , Neoplasias/psicología , Adolescente , Vestuario/psicología , Miedo , Femenino , Humanos , Relaciones Interpersonales , Masculino , Oncología Médica/métodos , Narración , Pediatría , Autoimagen , Autoeficacia , Adulto Joven
4.
Leuk Lymphoma ; 55(9): 2032-7, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24730540

RESUMEN

Immunomodulatory drugs (IMiDs) may favor autoimmune disease (AD) occurrence. We conducted a retrospective study to evaluate AD occurrence among IMiD-treated patients with myeloma. Patients were grouped into three classes depending on the type of IMiD engaged. The first group included patients treated with thalidomide (Thal) (n = 474), the second group with lenalidomide (Len) (n = 140) and patients in the third group were first treated with Thal followed by Len (Thal-Len) (n = 94). Absolute risk of AD was 0.4% for patients treated with Thal, 4.3% for Len and 1.1% for Thal-Len. ADs manifested prevalently as autoimmune cytopenias (55%), although we observed one vasculitis, one optic neuritis, one Graves' disease and one polymyositis. ADs occurred preferentially in the first months of IMiD treatment. A previous autologous transplant was shown to be a significant risk factor. All ADs were managed with IMiD discontinuation and steroids, resolving in a few weeks, except for Graves' disease and polymyositis.


Asunto(s)
Enfermedades Autoinmunes/complicaciones , Factores Inmunológicos/uso terapéutico , Mieloma Múltiple/complicaciones , Mieloma Múltiple/tratamiento farmacológico , Talidomida/análogos & derivados , Adulto , Anciano , Anciano de 80 o más Años , Enfermedades Autoinmunes/diagnóstico , Trasplante de Células Madre Hematopoyéticas , Humanos , Incidencia , Lenalidomida , Masculino , Persona de Mediana Edad , Mieloma Múltiple/patología , Mieloma Múltiple/terapia , Estadificación de Neoplasias , Estudios Retrospectivos , Talidomida/uso terapéutico , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA